thymidine has been researched along with Recrudescence in 37 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the therapeutic benefit of sequential interferon alpha-1b (IFNa-1b) in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) who showed early complete response to telbivudine (LdT) treatment, and to explore the clinical value of serum hepatitis B surface antigen (HBsAg) for predicting sustained virological response (SVR)." | 9.17 | [Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients]. ( Guo, SH; Sandeep, KK; Zhang, DZ; Zhang, QF; Zhang, W, 2013) |
| "Treatment of the acute disease with N-methanocarbathymidine significantly reduced the severity of acute disease and decreased acute vaginal virus shedding more effectively than acyclovir." | 7.81 | Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs. ( Bernstein, DI; Bravo, FJ; Cardin, RD; Glazer, RI; Pullum, DA; Rahman, A; Shen, H; Wang, M, 2015) |
| "In vitro and in vivo studies were done on a herpes simplex virus type 2 strain recovered from a patient on acyclovir (ACV) which was ACV resistant but expressed thymidine (dThd) kinase (EC 2." | 7.67 | Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. ( Barry, DW; Ellis, MN; Fyfe, JA; Keller, PM; Lehrman, SN; Martin, JL; Rooney, JF; Straus, SE, 1987) |
| "In 3,800 node-negative breast cancers recruited between 1972 and 1991, the consistency of information provided by the 3H-thymidine labelling index (TLI), in terms of basic relations with other clinico-pathological and biological variables and clinical predictivity, was evaluated using a combined analysis of results previously published by our group for distinct series of patients." | 5.30 | Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index. ( Daidone, MG; Leutner, M; Luisi, A; Mastore, M; Salvadori, B; Silvestrini, R, 1997) |
| "To investigate the therapeutic benefit of sequential interferon alpha-1b (IFNa-1b) in patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) who showed early complete response to telbivudine (LdT) treatment, and to explore the clinical value of serum hepatitis B surface antigen (HBsAg) for predicting sustained virological response (SVR)." | 5.17 | [Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients]. ( Guo, SH; Sandeep, KK; Zhang, DZ; Zhang, QF; Zhang, W, 2013) |
| "Treatment of the acute disease with N-methanocarbathymidine significantly reduced the severity of acute disease and decreased acute vaginal virus shedding more effectively than acyclovir." | 3.81 | Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs. ( Bernstein, DI; Bravo, FJ; Cardin, RD; Glazer, RI; Pullum, DA; Rahman, A; Shen, H; Wang, M, 2015) |
| "We investigated thymidine kinase (tk) mutants isolated during multiple episodes of recurrent bilateral acyclovir resistant herpes simplex keratitis in an immunocompetent patient." | 3.80 | Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient. ( Coen, DM; Hart, IJ; Hopkins, M; Kaye, SB; Kirwan, R; Pan, D, 2014) |
| "In vitro and in vivo studies were done on a herpes simplex virus type 2 strain recovered from a patient on acyclovir (ACV) which was ACV resistant but expressed thymidine (dThd) kinase (EC 2." | 3.67 | Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity. ( Barry, DW; Ellis, MN; Fyfe, JA; Keller, PM; Lehrman, SN; Martin, JL; Rooney, JF; Straus, SE, 1987) |
| "DNA synthesis time (Ts) and 3H thymidine (TdR) labelling index (LI) of bone marrow (BM) myelomatous plasma cells (PC) and of the residual haemopoietic cell population (RHCP) were measured by in vitro quantitative 14C-TdR autoradiography in five patients with multiple myeloma (MM) in different phases of disease (three at presentation and two at relapse) and in one patient with solitary extra-osseous myeloma." | 3.67 | Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma. ( Ciotti, R; Danova, M; Dörmer, P; Girino, M; Luoni, R; Montecucco, CM; Riccardi, A; Ucci, G, 1987) |
| "Thirty-eight patients with advanced HNSCC underwent 11C-4DST PET/CT and 18F-FDG PET/CT before treatment." | 1.42 | Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma. ( Ishiwata, K; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Morooka, M; Okasaki, M; Toyohara, J; Yokoyama, J, 2015) |
| "Lamivudine was switched to telbivudine." | 1.42 | Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy. ( Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S, 2015) |
| "Hepatitis B virus (HBV) recurrence after orthotopic liver transplantation (OLT) represents a severe condition that requires prophylaxis with specific immunoglobulin and lamivudine." | 1.38 | Telbivudin as prophylaxis for hepatitis B virus recurrence after liver transplantation: a case series in single-center experience. ( Amato, G; Calise, F; Cuomo, O; Dicostanzo, G; Lanza, AG; Marcos, A; Perrella, A; Pisaniello, D; Santaniello, W, 2012) |
| "In 3,800 node-negative breast cancers recruited between 1972 and 1991, the consistency of information provided by the 3H-thymidine labelling index (TLI), in terms of basic relations with other clinico-pathological and biological variables and clinical predictivity, was evaluated using a combined analysis of results previously published by our group for distinct series of patients." | 1.30 | Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index. ( Daidone, MG; Leutner, M; Luisi, A; Mastore, M; Salvadori, B; Silvestrini, R, 1997) |
| "This hypertriglyceridemia was found to be due to the absence of serum apolipoprotein C-II (apo C-II) which was identified by Western blotting using polyclonal anti-apo C-II antiserum." | 1.30 | A thymidine to cytosine substitution for codon 26 of exon 3 of apolipoprotein C-II gene in a patient with apolipoprotein C-II deficiency. ( Fuku, H; Kuniyoshi, A; Matsuyama, Y; Okamoto, Y; Tamagawa, T, 1999) |
| "We describe a patient with acute myelogenous leukemia (AML) who received his second autologous blood stem cell transplantation (ABSCT) following a G-CSF-combined pre-transplant conditioning regimen." | 1.29 | Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia. ( Akashi, K; Harada, M; Inaba, S; Niho, Y; Takamatsu, Y; Teshima, T, 1994) |
| "Spontaneous ocular recurrences were reduced during therapy, compared to saline-treated controls." | 1.28 | Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys. ( Bobek, M; Cheng, YC; Dutschman, GE; Kaufman, HE; Thompson, HW; Varnell, ED, 1991) |
| "This result is - compared with 53% recurrences of previous own cases before the use of a specific virostatic-considerably better." | 1.26 | [Herpetic recurrence prophylaxis with trifluorothymidine after keratoplasty (author's transl)]. ( Sie, SH, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (56.76) | 18.7374 |
| 1990's | 4 (10.81) | 18.2507 |
| 2000's | 1 (2.70) | 29.6817 |
| 2010's | 11 (29.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salpini, R | 1 |
| Alteri, C | 1 |
| Cento, V | 1 |
| Pollicita, M | 1 |
| Micheli, V | 1 |
| Gubertini, G | 1 |
| De Sanctis, GM | 1 |
| Visca, M | 1 |
| Romano, S | 1 |
| Sarrecchia, C | 1 |
| Andreoni, M | 1 |
| Angelico, M | 1 |
| Parruti, G | 1 |
| Svicher, V | 1 |
| Perno, CF | 2 |
| Wong, GL | 1 |
| Chan, HL | 1 |
| Lo, AO | 1 |
| Chan, HY | 1 |
| Tse, CH | 1 |
| Chim, AM | 1 |
| Wong, VW | 1 |
| Pan, D | 1 |
| Kaye, SB | 1 |
| Hopkins, M | 1 |
| Kirwan, R | 1 |
| Hart, IJ | 1 |
| Coen, DM | 1 |
| Zhang, W | 1 |
| Sandeep, KK | 1 |
| Zhang, QF | 1 |
| Guo, SH | 1 |
| Zhang, DZ | 1 |
| Chen, DB | 1 |
| Chen, YM | 1 |
| Liu, J | 1 |
| Xie, DY | 1 |
| Lu, CR | 1 |
| Huang, ZL | 1 |
| Zhu, RH | 1 |
| Gao, ZL | 1 |
| Perrella, A | 2 |
| Lanza, AG | 2 |
| Pisaniello, D | 2 |
| DiCostanzo, G | 2 |
| Calise, F | 2 |
| Cuomo, O | 2 |
| Ito, K | 1 |
| Yokoyama, J | 1 |
| Miyata, Y | 1 |
| Toyohara, J | 1 |
| Okasaki, M | 1 |
| Minamimoto, R | 1 |
| Morooka, M | 1 |
| Ishiwata, K | 1 |
| Kubota, K | 1 |
| Turan, I | 1 |
| Yapali, S | 1 |
| Bademkiran, F | 1 |
| Kose, T | 1 |
| Duman, S | 1 |
| Sozbilen, M | 1 |
| Gunsar, F | 1 |
| Ersoz, G | 1 |
| Akarca, US | 1 |
| Ozutemiz, O | 1 |
| Karasu, Z | 1 |
| Bernstein, DI | 1 |
| Bravo, FJ | 1 |
| Pullum, DA | 1 |
| Shen, H | 1 |
| Wang, M | 1 |
| Rahman, A | 1 |
| Glazer, RI | 1 |
| Cardin, RD | 1 |
| Pan, HY | 2 |
| Chen, L | 1 |
| Yang, DH | 1 |
| Huang, HJ | 1 |
| Tong, YX | 1 |
| Chen, CR | 1 |
| Yan, J | 1 |
| Santaniello, W | 1 |
| Amato, G | 1 |
| Marcos, A | 1 |
| Violin, M | 1 |
| Cozzi-Lepri, A | 1 |
| Velleca, R | 1 |
| Vincenti, A | 1 |
| D'Elia, S | 1 |
| Chiodo, F | 1 |
| Ghinelli, F | 1 |
| Bertoli, A | 1 |
| d'Arminio Monforte, A | 1 |
| Moroni, M | 1 |
| Balotta, C | 1 |
| Sie, SH | 1 |
| Peavy, DL | 1 |
| Nelms, DC | 1 |
| Mackler, BF | 1 |
| Knight, SC | 1 |
| Harding, B | 1 |
| Burman, S | 1 |
| Mertin, J | 1 |
| Drewinko, B | 2 |
| Alexanian, R | 2 |
| Boyer, H | 1 |
| Barlogie, B | 1 |
| Rubinow, SI | 1 |
| Takamatsu, Y | 1 |
| Teshima, T | 1 |
| Akashi, K | 1 |
| Inaba, S | 1 |
| Harada, M | 1 |
| Niho, Y | 1 |
| Silvestrini, R | 1 |
| Daidone, MG | 1 |
| Luisi, A | 1 |
| Mastore, M | 1 |
| Leutner, M | 1 |
| Salvadori, B | 1 |
| Kuniyoshi, A | 1 |
| Okamoto, Y | 1 |
| Tamagawa, T | 1 |
| Matsuyama, Y | 1 |
| Fuku, H | 1 |
| Bigar, F | 1 |
| Meyer, JS | 1 |
| Hixon, B | 1 |
| Sassa, S | 1 |
| Zalar, GL | 1 |
| Kappas, A | 1 |
| Coster, DJ | 1 |
| McKinnon, JR | 1 |
| McGill, JI | 1 |
| Jones, BR | 1 |
| Fraunfelder, FT | 1 |
| Hoelzer, D | 1 |
| Schmücker, H | 1 |
| Kurrle, E | 1 |
| Kaufman, HE | 1 |
| Varnell, ED | 1 |
| Cheng, YC | 1 |
| Bobek, M | 1 |
| Thompson, HW | 1 |
| Dutschman, GE | 1 |
| Ellis, MN | 1 |
| Keller, PM | 1 |
| Fyfe, JA | 1 |
| Martin, JL | 1 |
| Rooney, JF | 1 |
| Straus, SE | 1 |
| Lehrman, SN | 1 |
| Barry, DW | 1 |
| Ucci, G | 1 |
| Riccardi, A | 1 |
| Dörmer, P | 1 |
| Danova, M | 1 |
| Luoni, R | 1 |
| Montecucco, CM | 1 |
| Ciotti, R | 1 |
| Girino, M | 1 |
| Colin, J | 1 |
| Chastel, C | 1 |
| Donovan, R | 1 |
| Soothill, JF | 1 |
| O'Grady, FW | 1 |
| Rasmussen, LE | 1 |
| Jordan, GW | 1 |
| Stevens, DA | 1 |
| Merigan, TC | 1 |
| Han, T | 1 |
| Wang, J | 1 |
| Folb, PI | 1 |
| Ramot, B | 1 |
| Dannenberg, AM | 1 |
| Ando, M | 1 |
| Shima, K | 1 |
| Rich, RR | 1 |
| Kirkpatrick, CH | 1 |
| Rosenthal, AS | 1 |
4 trials available for thymidine and Recrudescence
| Article | Year |
|---|---|
[Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients].
Topics: Adult; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; I | 2013 |
Trifluridine (viroptic) for herpetic keratitis.
Topics: Antiviral Agents; Clinical Trials as Topic; Corneal Ulcer; Humans; Keratitis, Dendritic; Recurrence; | 1980 |
Cell number requirements for lymphocyte stimulation in vitro: changes during the course of multiple sclerosis and the effects of immunosuppression.
Topics: Adult; Azathioprine; Cells, Cultured; Clinical Trials as Topic; Humans; Immunosuppressive Agents; Le | 1981 |
Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus.
Topics: Administration, Topical; Clinical Trials as Topic; Corneal Ulcer; Drug Evaluation; Humans; Keratitis | 1976 |
33 other studies available for thymidine and Recrudescence
| Article | Year |
|---|---|
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanin | 2013 |
Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Anti | 2013 |
Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient.
Topics: Acyclovir; Adult; Amino Acid Substitution; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Her | 2014 |
Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; | 2014 |
Telbivudine prophylaxis for hepatitis B virus recurrence after liver transplantation improves renal function.
Topics: Adult; Antiviral Agents; Creatinine; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transpl | 2014 |
Volumetric comparison of positron emission tomography/computed tomography using 4'-[methyl-¹¹C]-thiothymidine with 2-deoxy-2-¹⁸F-fluoro-D-glucose in patients with advanced head and neck squamous cell carcinoma.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Ki- | 2015 |
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glome | 2015 |
Efficacy of N-methanocarbathymidine against genital herpes simplex virus type 2 shedding and infection in guinea pigs.
Topics: Acute Disease; Animals; Antiviral Agents; Disease Models, Animal; Female; Guinea Pigs; Herpes Genita | 2015 |
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients.
Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Feasibility Studies; Female; Follow-Up Studies; Hep | 2015 |
Telbivudin as prophylaxis for hepatitis B virus recurrence after liver transplantation: a case series in single-center experience.
Topics: Adult; Case-Control Studies; Female; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; | 2012 |
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.
Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Chronic Disease; Cohort Studies; Drug Resistance | 2004 |
[Herpetic recurrence prophylaxis with trifluorothymidine after keratoplasty (author's transl)].
Topics: Adolescent; Adult; Aged; Corneal Transplantation; Female; Humans; Keratitis, Dendritic; Male; Middle | 1980 |
Failure of autologous oral epithelia to activate RAS lymphocytes.
Topics: Behcet Syndrome; Epithelial Cells; Epithelium; Humans; Lymphocyte Activation; Mitomycin; Mitomycins; | 1982 |
The growth fraction of human myeloma cells.
Topics: Female; Humans; Kinetics; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Recurrence; Th | 1981 |
Successful second autologous blood stem cell transplantation after G-CSF-combined conditioning for the treatment of high-risk acute myelogenous leukemia.
Topics: Adult; Blood Transfusion, Autologous; Combined Modality Therapy; Cytarabine; DNA, Neoplasm; Drug The | 1994 |
Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Cell Division; Confidence Intervals; DNA, Neoplasm | 1997 |
A thymidine to cytosine substitution for codon 26 of exon 3 of apolipoprotein C-II gene in a patient with apolipoprotein C-II deficiency.
Topics: Apolipoprotein C-II; Apolipoproteins C; Blotting, Western; Codon; Cytosine; DNA; DNA Primers; Exons; | 1999 |
Clinical experiences with trifluorothymidine in herpes simplex keratitis.
Topics: Animals; Corneal Transplantation; Deoxycytidine; Female; Humans; Idoxuridine; Keratitis, Dendritic; | 1979 |
Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices.
Topics: Age Factors; Aged; Breast Neoplasms; DNA, Neoplasm; Female; Humans; Lymphatic Metastasis; Middle Age | 1979 |
Studies in porphyria. VII. Induction of uroporphyrinogen-I synthase and expression of the gene defect of acute intermittent porphyria in mitogen-stimulated human lymphocytes.
Topics: Acute Disease; Adolescent; Adult; Aged; Ammonia-Lyases; Cells, Cultured; Child; Child, Preschool; En | 1978 |
Growth kinetics of plasma cell myeloma.
Topics: Bone Marrow; Bone Marrow Cells; Cell Division; Female; Humans; In Vitro Techniques; Infusions, Paren | 1977 |
Re-entry of resting leukaemic blood cells into proliferation in human acute leukaemia during diffusion chamber culture.
Topics: Acute Disease; Cell Division; Cells, Cultured; Humans; Leukemia; Recurrence; Thymidine; Tritium | 1976 |
Suppression of ocular herpes recurrences by a thymidine kinase inhibitor in squirrel monkeys.
Topics: Animals; Keratitis, Herpetic; Recurrence; Saimiri; Simplexvirus; Thymidine; Thymidine Kinase; Viral | 1991 |
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Topics: Acyclovir; Adult; Animals; Antiviral Agents; Arabinonucleosides; Cloning, Molecular; DNA Restriction | 1987 |
Proliferation kinetics of plasma cells and of normal haemopoietic cells in multiple myeloma.
Topics: Aged; Bone Marrow; Cell Division; DNA; Female; Hematopoietic Stem Cells; Humans; Kinetics; Leukemia, | 1987 |
[Early treatment of ocular herpes simplex. Apropos of 6 cases of herpetic conjunctivitis].
Topics: Adult; Conjunctivitis, Viral; Female; Humans; Keratitis, Dendritic; Male; Middle Aged; Ophthalmic So | 1985 |
Immunological studies in children undergoing tonsillectomy.
Topics: Animals; Antistreptolysin; Cells, Cultured; Child; Child, Preschool; Female; Haemophilus influenzae; | 1973 |
Co-trimaxazole therapy: place and prospects.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacteriuria; Drug Combinations; Drug Resistance, Microbial | 1973 |
Lymphocyte interferon production and transformation after Herpes simplex infections in humans.
Topics: Antibodies, Viral; Antigens, Viral; Cells, Cultured; Cytopathogenic Effect, Viral; Fibroblasts; HeLa | 1974 |
'Antigenic' disparity between leukaemic lymphoblasts and normal lymphocytes in identical twins.
Topics: Acute Disease; Antigens, Neoplasm; Child, Preschool; Diseases in Twins; Histocompatibility Testing; | 1972 |
Autoradiography of activated lymphocytes in the blood in Hodgkin's disease.
Topics: Adolescent; Adult; Age Factors; Antigens; Autoradiography; DNA; Female; Hodgkin Disease; Humans; Lym | 1973 |
Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. 3. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinfection
Topics: Animals; Autoradiography; Cell Division; Cell Survival; Galactosidases; Hypersensitivity, Delayed; I | 1972 |
Photosensitive cheilitis. Clinical and pathogenetic considerations.
Topics: Adult; Biopsy; Black People; Cheilitis; Chronic Disease; Cytoplasmic Granules; Diagnosis, Differenti | 1971 |